JP4949898B2 - 血球分析装置 - Google Patents
血球分析装置 Download PDFInfo
- Publication number
- JP4949898B2 JP4949898B2 JP2007061093A JP2007061093A JP4949898B2 JP 4949898 B2 JP4949898 B2 JP 4949898B2 JP 2007061093 A JP2007061093 A JP 2007061093A JP 2007061093 A JP2007061093 A JP 2007061093A JP 4949898 B2 JP4949898 B2 JP 4949898B2
- Authority
- JP
- Japan
- Prior art keywords
- information
- hemoglobin
- scattered light
- reticulocyte
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000000601 blood cell Anatomy 0.000 title claims description 33
- 108010054147 Hemoglobins Proteins 0.000 claims description 79
- 102000001554 Hemoglobins Human genes 0.000 claims description 79
- 210000001995 reticulocyte Anatomy 0.000 claims description 71
- 210000003743 erythrocyte Anatomy 0.000 claims description 69
- 238000005259 measurement Methods 0.000 claims description 41
- 238000004458 analytical method Methods 0.000 claims description 30
- 238000010586 diagram Methods 0.000 claims description 27
- 238000012360 testing method Methods 0.000 claims description 19
- 210000004369 blood Anatomy 0.000 claims description 17
- 239000008280 blood Substances 0.000 claims description 17
- 238000007405 data analysis Methods 0.000 claims description 17
- 238000001514 detection method Methods 0.000 claims description 15
- 230000003287 optical effect Effects 0.000 claims description 14
- 206010022971 Iron Deficiencies Diseases 0.000 claims description 12
- 210000004027 cell Anatomy 0.000 claims description 11
- 238000003860 storage Methods 0.000 claims description 9
- 230000015572 biosynthetic process Effects 0.000 claims description 8
- 238000003786 synthesis reaction Methods 0.000 claims description 8
- 230000000215 hyperchromic effect Effects 0.000 claims description 4
- 208000037581 Persistent Infection Diseases 0.000 claims description 3
- 230000001678 irradiating effect Effects 0.000 claims description 3
- 230000001154 acute effect Effects 0.000 claims description 2
- 208000015181 infectious disease Diseases 0.000 claims description 2
- 230000028709 inflammatory response Effects 0.000 claims 2
- 239000000049 pigment Substances 0.000 claims 1
- 238000012545 processing Methods 0.000 description 25
- 238000009826 distribution Methods 0.000 description 17
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 12
- 230000007246 mechanism Effects 0.000 description 11
- 208000007502 anemia Diseases 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 238000000034 method Methods 0.000 description 8
- 239000012530 fluid Substances 0.000 description 7
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 6
- 210000001772 blood platelet Anatomy 0.000 description 6
- 229910052742 iron Inorganic materials 0.000 description 6
- 238000005070 sampling Methods 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 238000004364 calculation method Methods 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 210000000265 leukocyte Anatomy 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 206010002065 Anaemia megaloblastic Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 208000000682 Megaloblastic Anemia Diseases 0.000 description 3
- 206010058116 Nephrogenic anaemia Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 231100001016 megaloblastic anemia Toxicity 0.000 description 3
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 3
- 238000012552 review Methods 0.000 description 3
- 239000012192 staining solution Substances 0.000 description 3
- 102000003951 Erythropoietin Human genes 0.000 description 2
- 108090000394 Erythropoietin Proteins 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- 210000003651 basophil Anatomy 0.000 description 2
- 238000004590 computer program Methods 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940105423 erythropoietin Drugs 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000001668 nucleic acid synthesis Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 206010002064 Anaemia macrocytic Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 108010092408 Eosinophil Peroxidase Proteins 0.000 description 1
- 102100031939 Erythropoietin Human genes 0.000 description 1
- 102000008857 Ferritin Human genes 0.000 description 1
- 108050000784 Ferritin Proteins 0.000 description 1
- 238000008416 Ferritin Methods 0.000 description 1
- 206010016880 Folate deficiency Diseases 0.000 description 1
- 208000010188 Folic Acid Deficiency Diseases 0.000 description 1
- 101000987586 Homo sapiens Eosinophil peroxidase Proteins 0.000 description 1
- 101000920686 Homo sapiens Erythropoietin Proteins 0.000 description 1
- 206010020605 Hyperchromic anaemia Diseases 0.000 description 1
- 208000003367 Hypopigmentation Diseases 0.000 description 1
- 102000007238 Transferrin Receptors Human genes 0.000 description 1
- 108010033576 Transferrin Receptors Proteins 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 208000005980 beta thalassemia Diseases 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 108010036302 hemoglobin AS Proteins 0.000 description 1
- 239000003219 hemolytic agent Substances 0.000 description 1
- 102000044890 human EPO Human genes 0.000 description 1
- 230000003425 hypopigmentation Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 201000006437 macrocytic anemia Diseases 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1456—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals
- G01N15/1459—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals the analysis being performed on a sample stream
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/1031—Investigating individual particles by measuring electrical or magnetic effects
- G01N15/12—Investigating individual particles by measuring electrical or magnetic effects by observing changes in resistance or impedance across apertures when traversed by individual particles, e.g. by using the Coulter principle
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/491—Blood by separating the blood components
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
- G01N2015/012—Red blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
- G01N2015/012—Red blood cells
- G01N2015/014—Reticulocytes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
- G01N2015/018—Platelets
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N2015/1019—Associating Coulter-counter and optical flow cytometer [OFC]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N2015/1477—Multiparameters
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Dispersion Chemistry (AREA)
- Ecology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007061093A JP4949898B2 (ja) | 2007-03-09 | 2007-03-09 | 血球分析装置 |
| EP08003550.4A EP1967840A3 (en) | 2007-03-09 | 2008-02-27 | Hematology analyzer, hematology analyzing method, and computer program product |
| US12/044,780 US20080268494A1 (en) | 2007-03-09 | 2008-03-07 | Hematology analyzer, hematology analyzing method, and computer program product |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007061093A JP4949898B2 (ja) | 2007-03-09 | 2007-03-09 | 血球分析装置 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008224337A JP2008224337A (ja) | 2008-09-25 |
| JP2008224337A5 JP2008224337A5 (cg-RX-API-DMAC10.html) | 2010-04-15 |
| JP4949898B2 true JP4949898B2 (ja) | 2012-06-13 |
Family
ID=39494506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007061093A Expired - Fee Related JP4949898B2 (ja) | 2007-03-09 | 2007-03-09 | 血球分析装置 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20080268494A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1967840A3 (cg-RX-API-DMAC10.html) |
| JP (1) | JP4949898B2 (cg-RX-API-DMAC10.html) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8906309B2 (en) | 2009-04-27 | 2014-12-09 | Abbott Laboratories | Method for discriminating red blood cells from white blood cells by using forward scattering from a laser in an automated hematology analyzer |
| US8911669B2 (en) | 2009-08-24 | 2014-12-16 | Abbott Laboratories | Method for flagging a sample |
| JP5667353B2 (ja) * | 2009-09-25 | 2015-02-12 | シスメックス株式会社 | 血球計数装置、診断支援装置、診断支援方法及びコンピュータプログラム |
| JP5530691B2 (ja) * | 2009-09-25 | 2014-06-25 | シスメックス株式会社 | 血球計数装置、診断支援装置、診断支援方法及びコンピュータプログラム |
| US9134336B2 (en) * | 2009-10-16 | 2015-09-15 | Canadian Blood Services | Dual analyzer system for biological fluid |
| US8906308B2 (en) * | 2010-01-15 | 2014-12-09 | Abbott Laboratories | Method for determining volume and hemoglobin content of individual red blood cells |
| FR2956207B1 (fr) | 2010-02-10 | 2012-05-04 | Horiba Abx Sas | Dispositif et procede de mesures multiparametriques de microparticules dans un fluide |
| JP5868982B2 (ja) | 2010-09-16 | 2016-02-24 | ザ ジェネラル ホスピタル コーポレイション | 診断のための赤血球動力学 |
| US9005909B2 (en) | 2011-01-06 | 2015-04-14 | Rigel Pharmaceuticals, Inc. | Whole blood assay for measuring AMPK activation |
| US9317653B2 (en) * | 2011-07-22 | 2016-04-19 | Sysmex Corporation | Analyzer, and method for performing a measurement on a sample |
| US10514385B2 (en) | 2011-07-22 | 2019-12-24 | Sysmex Corporation | Hematology analyzer, method, and system for quality control measurements |
| US9297819B2 (en) * | 2011-07-22 | 2016-03-29 | Sysmex Corporation | Hematology analyzing system and analyzer |
| CN104458541A (zh) * | 2013-09-12 | 2015-03-25 | 深圳迈瑞生物医疗电子股份有限公司 | 红细胞血红蛋白含量的分析方法、装置及血液细胞分析仪 |
| JP6370659B2 (ja) * | 2014-09-26 | 2018-08-08 | シスメックス株式会社 | 血液分析装置および血液分析方法 |
| US9766224B2 (en) | 2015-03-25 | 2017-09-19 | The Board Of Trustees Of The Leland Stanford Junior University | Single cell analysis using secondary ion mass spectrometry |
| US10955423B2 (en) | 2015-12-15 | 2021-03-23 | The General Hospital Corporation | Methods of estimating blood glucose and related systems |
| JP6932894B2 (ja) | 2016-01-28 | 2021-09-08 | シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレーテッドＳｉｅｍｅｎｓ Ｈｅａｌｔｈｃａｒｅ Ｄｉａｇｎｏｓｔｉｃｓ Ｉｎｃ． | 複数の露光を使用して試料容器及び／又は試料を画像化するための方法及び装置 |
| EP3408646B1 (en) | 2016-01-28 | 2024-05-29 | Siemens Healthcare Diagnostics Inc. | Methods and apparatus for characterizing a specimen container and a specimen |
| US11293852B2 (en) | 2016-04-07 | 2022-04-05 | The General Hospital Corporation | White blood cell population dynamics |
| WO2017180420A1 (en) | 2016-04-11 | 2017-10-19 | Board Of Regents, The University Of Texas System | Methods and compositions for detecting single t cell receptor affinity and sequence |
| EP3538870B1 (en) | 2016-11-14 | 2024-09-04 | Siemens Healthcare Diagnostics Inc. | Methods and apparatus for characterizing a specimen using pattern illumination |
| EP3655757B1 (en) | 2017-07-19 | 2025-04-16 | Siemens Healthcare Diagnostics, Inc. | Apparatus and method for specimen characterization using hyperspectral imaging |
| US11815519B2 (en) | 2017-07-19 | 2023-11-14 | Siemens Healthcare Diagnostics Inc. | Stray light compensating methods and apparatus for characterizing a specimen |
| JP6983997B2 (ja) | 2017-07-31 | 2021-12-17 | シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレーテッドSiemens Healthcare Diagnostics Inc. | 試料または試料容器の特性を評価する方法および装置 |
| JP6983998B2 (ja) | 2017-07-31 | 2021-12-17 | シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレーテッドSiemens Healthcare Diagnostics Inc. | 試料または試料容器の画像化の方法および装置 |
| CN111602046B (zh) * | 2018-04-28 | 2024-01-09 | 深圳迈瑞生物医疗电子股份有限公司 | 一种血液分析仪及分析方法 |
| JP7238300B2 (ja) * | 2018-09-04 | 2023-03-14 | 株式会社島津製作所 | 分析システム、表示制御方法および表示制御プログラム |
| WO2020146967A1 (zh) * | 2019-01-14 | 2020-07-23 | 深圳迈瑞生物医疗电子股份有限公司 | 一种样本光学检测装置 |
| EP4076756B1 (en) * | 2019-12-20 | 2025-07-09 | Roche Diagnostics Hematology, Inc. | Linearity control compositions and methods of use |
| WO2021207894A1 (zh) * | 2020-04-13 | 2021-10-21 | 深圳迈瑞生物医疗电子股份有限公司 | 细胞分析方法、细胞分析仪及计算机可读存储介质 |
| CN114062696A (zh) * | 2020-08-04 | 2022-02-18 | 深圳迈瑞生物医疗电子股份有限公司 | 血样测量方法、血液测量装置、电子设备及计算机可读存储介质 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4735504A (en) * | 1983-10-31 | 1988-04-05 | Technicon Instruments Corporation | Method and apparatus for determining the volume & index of refraction of particles |
| JP4101994B2 (ja) * | 1999-01-21 | 2008-06-18 | シスメックス株式会社 | 粒子分析装置および自動粒子分析方法 |
| WO2003025583A2 (en) * | 2001-09-14 | 2003-03-27 | F. Hoffmann-La Roche Ag | Differential diagnosis of disorders of iron metabolism |
| JP4221228B2 (ja) * | 2002-01-18 | 2009-02-12 | シスメックス株式会社 | 塗抹標本作製装置 |
| JP4474135B2 (ja) * | 2002-09-10 | 2010-06-02 | シスメックス株式会社 | 網状赤血球測定方法及び装置 |
| JP4417143B2 (ja) | 2004-03-11 | 2010-02-17 | シスメックス株式会社 | 試料分析装置、プログラムおよびそのプログラムを記録した記録媒体 |
| US7541190B2 (en) * | 2005-02-07 | 2009-06-02 | Beckman Coulter, Inc. | Method of measurement of cellular hemoglobin |
-
2007
- 2007-03-09 JP JP2007061093A patent/JP4949898B2/ja not_active Expired - Fee Related
-
2008
- 2008-02-27 EP EP08003550.4A patent/EP1967840A3/en not_active Withdrawn
- 2008-03-07 US US12/044,780 patent/US20080268494A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1967840A3 (en) | 2013-07-17 |
| US20080268494A1 (en) | 2008-10-30 |
| EP1967840A2 (en) | 2008-09-10 |
| JP2008224337A (ja) | 2008-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008224337A (ja) | 血球分析装置 | |
| JP4417143B2 (ja) | 試料分析装置、プログラムおよびそのプログラムを記録した記録媒体 | |
| US8017078B2 (en) | Blood cell analyzer, blood cell analyzing method, and computer program product | |
| JP5670052B2 (ja) | 血液分析装置、血液分析方法及びコンピュータプログラム | |
| JP5025371B2 (ja) | 血液分析装置 | |
| JP4994920B2 (ja) | 検体分析装置 | |
| JP4926812B2 (ja) | 血球分析装置および体液分析方法 | |
| JP5667353B2 (ja) | 血球計数装置、診断支援装置、診断支援方法及びコンピュータプログラム | |
| US10113966B2 (en) | Blood analyzer, diagnostic support method, and non-transitory storage medium | |
| JP5530691B2 (ja) | 血球計数装置、診断支援装置、診断支援方法及びコンピュータプログラム | |
| JP6170865B2 (ja) | 血液分析装置 | |
| Tantanate et al. | Performance evaluation of automated impedance and optical fluorescence platelet counts compared with international reference method in patients with thalassemia | |
| JP4969596B2 (ja) | 試料分析装置、試料分析方法およびプログラム | |
| JP2020060601A (ja) | 検体検査システム、情報処理装置、情報処理方法、およびプログラム | |
| CN117529648B (zh) | 一种样本分析装置和样本分析方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100225 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100225 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20110513 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110607 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110713 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20110812 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120214 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120308 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150316 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |